Severe antiphospholipid antibody syndrome - response to plasmapheresis and rituximab.

scientific article

Severe antiphospholipid antibody syndrome - response to plasmapheresis and rituximab. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/09546634.2017.1282599
P698PubMed publication ID28084106

P50authorTobias GoergeQ89918108
P2093author name stringParaskevi Gkogkolou
Jan Ehrchen
P2860cites workAntiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsQ33341941
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndromeQ33404206
Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximabQ38115382
Recent advances in the antiphospholipid antibody syndromeQ38229433
Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosisQ39938037
P433issue6
P304page(s)564-566
P577publication date2017-02-01
P1433published inJournal of Dermatological TreatmentQ6295084
P1476titleSevere antiphospholipid antibody syndrome - response to plasmapheresis and rituximab
P478volume28

Reverse relations

Q41097173Autoimmune Thrombotic Thrombocytopenic Purpura: Two Rare Cases Associated with Juvenile Idiopathic Arthritis and Multiple Sclerosis.cites workP2860

Search more.